SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-038533 from Biofrontera Inc. (BFRI)

Biofrontera Inc.
Date: Oct. 27, 2023 · CIK: 0001858685 · Accession: 0001493152-23-038533

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-274871

Date
Oct. 27, 2023
Author
Chief
Form
CORRESP
Company
Biofrontera Inc.

Letter

Biofrontera Inc. · 120 Presidential Way, Suite 330 · Woburn, MA 01801 · USA

VIA EDGAR

October 27, 2023

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, N.E.

Washington, D.C. 20549

Re: Biofrontera Inc.

Registration Statement on Form S-1 (File No. 333-274871)

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biofrontera Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the “Registration Statement”) so that the Registration Statement will be declared effective as of 4:30 p.m. Eastern time, on October 30, 2023, or as soon thereafter as practicable. The Registrant hereby also authorizes Stephen Older, Elizabeth Jones and Lawton Way of McGuireWoods LLP to orally modify or withdraw this request for acceleration.

Once the Registration Statement has been declared effective, please orally confirm that event with Stephen Older of McGuireWoods LLP at (212) 548-2122, or in his absence, Elizabeth Jones at (704) 373-8847 or Lawton Way at (804) 775-4711.

Thank you for your assistance in this matter.

Very truly yours,
Biofrontera Inc.

Show Raw Text
CORRESP
1
filename1.htm

Biofrontera
Inc. · 120 Presidential Way, Suite 330 · Woburn, MA 01801 · USA

VIA
EDGAR

October
27, 2023

Securities
and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Biofrontera
    Inc.

    Registration
    Statement on Form S-1 (File No. 333-274871)

    Request
    for Acceleration of Effective Date

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Biofrontera Inc. (the “Registrant”) hereby requests that
the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration
Statement on Form S-1 (as amended, the “Registration Statement”) so that the Registration Statement will be declared
effective as of 4:30 p.m. Eastern time, on October 30, 2023, or as soon thereafter as practicable. The
Registrant hereby also authorizes Stephen Older, Elizabeth Jones and Lawton Way of McGuireWoods LLP to orally modify or withdraw this
request for acceleration.

Once
the Registration Statement has been declared effective, please orally confirm that event with Stephen Older of McGuireWoods LLP at (212)
548-2122, or in his absence, Elizabeth Jones at (704) 373-8847 or Lawton Way at (804) 775-4711.

Thank
you for your assistance in this matter.

    Very truly yours,

    Biofrontera Inc.

    /s/
    E. Fred Leffler, III

    Name:
    E.
Fred Leffler, III

    Title:
    Chief
    Financial Officer

    cc:
    Hermann
    Luebbert

    Biofrontera
    Inc.

    Stephen
    Older

    McGuireWoods
    LLP

Biofrontera
Inc. . 120 Presidential Way, Suite 330 . Woburn, MA 01801 . USA

Contact
Phone +1 781 245 1325 . E-Mail info-us@biofrontera.com . www.biofrontera-us.com